Leading cryptocurrencies traded sideways on Wednesday, as the Federal Reserve warned of macroeconomic dangers from President Donald Trump’s tariff moves.
The offering comes on the heels of encouraging data from the Virage Phase 2b trial, which demonstrated significant improvements in overall survival and duration of response for patients receiving Theriva's lead product candidate, VCN-01.
It wasn’t an inspiring day. There was a lot of back-and-forth trading, followed by a late surge on news that the Trump team plans to rescind the Biden-era AI diffusion rule and replace it with something better.
ZyVersa's IC 100 strategy focuses on targeting inflammasome-driven inflammation to enhance weight loss and improve metabolic function in obesity patients.
Jeff Bezos has long admired Sony's mission to elevate Japan's global image, and over the past 40 years, a $1,000 investment in Sony stock would have grown to more than $21,000, reflecting the company's lasting success.
With all the volatility and relentless selloffs, it’s a little surprising not to see more aggressive trade signals right now. Of the current setups, Verizon, Kinder Morgan, and Amgen stand out:
Business transformation services company Genpact (NYSE:G) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 7.4% year on year to $1.21 billion. On the other hand, next quarter’s revenue guidance of $1.22 billion was less impressive, coming in 2.3% below analysts’ estimates. Its non-GAAP profit of $0.84 per share was 5.8% above analysts’ consensus estimates.
Telecom software provider Amdocs (NASDAQ:DOX) met Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 9.4% year on year to $1.13 billion. The company expects next quarter’s revenue to be around $1.13 billion, close to analysts’ estimates. Its non-GAAP profit of $1.78 per share was 4.5% above analysts’ consensus estimates.
Performance marketing company QuinStreet (NASDAQ:QNST) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 60.1% year on year to $269.8 million. Its non-GAAP profit of $0.21 per share was in line with analysts’ consensus estimates.
Virtual events software company (NYSE:ONTF) announced better-than-expected revenue in Q1 CY2025, but sales fell by 7.9% year on year to $34.73 million. On the other hand, next quarter’s revenue guidance of $34.8 million was less impressive, coming in 0.7% below analysts’ estimates. Its non-GAAP loss of $0.01 per share was $0.01 above analysts’ consensus estimates.
Residential solar energy company Sunrun (NASDAQ:RUN) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 10.1% year on year to $504.3 million. Its GAAP profit of $0.20 per share was significantly above analysts’ consensus estimates.
Beverage company Zevia (NYSE:ZVIA) reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales fell by 2% year on year to $38.02 million. The company expects the full year’s revenue to be around $160.5 million, close to analysts’ estimates. Its GAAP loss of $0.08 per share was 31% above analysts’ consensus estimates.
